Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial.
Rugo HS, Pennella EJ, Gopalakrishnan U, Hernandez-Bronchud M, Herson J, Koch HF, Loganathan S, Deodhar S, Marwah A, Manikhas A, Bondarenko I, Parra JD, Abesamis-Tiambeng MLT, Akewanlop C, Vynnychenko I, Sriuranpong V, Roy S, Yanez Ruiz EP, Barve A, Waller CF. Rugo HS, et al. Among authors: koch hf. Breast. 2021 Aug;58:18-26. doi: 10.1016/j.breast.2021.03.009. Epub 2021 Apr 1. Breast. 2021. PMID: 33892316 Free PMC article. Clinical Trial.
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Rugo HS, Pennella EJ, Gopalakrishnan U, Hernandez-Bronchud M, Herson J, Koch HF, Loganathan S, Deodhar S, Marwah A, Manikhas A, Bondarenko I, Mukhametshina G, Nemsadze G, Parra JD, Abesamis-Tiambeng MLT, Baramidze K, Akewanlop C, Vynnychenko I, Sriuranpong V, Mamillapalli G, Roy S, Yanez Ruiz EP, Barve A, Fuentes-Alburo A, Waller CF. Rugo HS, et al. Among authors: koch hf. Breast Cancer Res Treat. 2021 Jul;188(2):369-377. doi: 10.1007/s10549-021-06197-5. Epub 2021 Jun 14. Breast Cancer Res Treat. 2021. PMID: 34125340 Free PMC article. Clinical Trial.
Prognostic factors for long-term survival after adult liver transplantation.
Filali Bouami S, Gwiasda J, Beneke J, Kaltenborn A, Liersch S, Suero EM, Koch HF, Krauth C, Klempnauer J, Schrem H. Filali Bouami S, et al. Among authors: koch hf. Langenbecks Arch Surg. 2018 Jun;403(4):495-508. doi: 10.1007/s00423-018-1670-5. Epub 2018 Apr 2. Langenbecks Arch Surg. 2018. PMID: 29610975
Statistical approach to quality assessment in liver transplantation.
Schrem H, Volz S, Koch HF, Gwiasda J, Kürsch P, Goldis A, Pöhnert D, Winny M, Klempnauer J, Kaltenborn A. Schrem H, et al. Among authors: koch hf. Langenbecks Arch Surg. 2018 Feb;403(1):61-71. doi: 10.1007/s00423-017-1612-7. Epub 2017 Sep 9. Langenbecks Arch Surg. 2018. PMID: 28889185
New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.
Foucher C, Aubonnet P, Reichert P, Berli M, Schaeffer A, Calvo Vargas CG, Lochocka A, Belenky D, Koch HF; Cholib study Investigators. Foucher C, et al. Among authors: koch hf. Cardiovasc Ther. 2015 Dec;33(6):329-37. doi: 10.1111/1755-5922.12148. Cardiovasc Ther. 2015. PMID: 26227087 Free article. Clinical Trial.
25 results